Everence Capital Management Inc Charles River Laboratories International, Inc. Transaction History
Everence Capital Management Inc
- $1.67 Billion
- Q3 2025
A detailed history of Everence Capital Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 1,279 shares of CRL stock, worth $214,628. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,279
Previous 1,920
33.39%
Holding current value
$214,628
Previous $291,000
31.27%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
659Shares Held
51.5MCall Options Held
194KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA5.89MShares$988 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2MShares$335 Million0.62% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...